Zai Lab (ZLAB) Capital Expenditures (2018 - 2026)
Zai Lab (ZLAB) posted quarterly Capital Expenditures of $1.2 million for Q1 2026, down 22.1% year-on-year from $1.5 million in Q1 2025, and up 76.51% on a QoQ basis from $677000.0 in Q4 2025.
Zai Lab (ZLAB) Capital Expenditures (2018 - 2026) Analysis & Trends
Zai Lab (ZLAB) has reported Capital Expenditures for 9 consecutive years, with $1.2 million the latest figure, recorded in Q1 2026.
- Quarterly Capital Expenditures fell 22.1% year-over-year to $1.2 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $7.8 million (up 24.85% YoY) and the FY2025 annual result came in at $8.1 million, up 43.2% from the prior year.
- Capital Expenditures advanced to $1.2 million in Q1 2026 per ZLAB's latest filing, from $677000.0 in the prior quarter.
- Over the last five years, Capital Expenditures for ZLAB reached as high as $9.7 million in Q1 2022 and fell as low as $222000.0 in Q4 2023.
- A 5-year average of $2.8 million and a median of $1.8 million in 2023 frame the typical range for Capital Expenditures.
- Annual changes were most pronounced in 2023 — Capital Expenditures plunged 94.97% — and 2024, when it surged 1071.17%.
- Year by year, Capital Expenditures stood at $4.4 million in 2022, then tumbled by 94.97% to $222000.0 in 2023, then jumped by 1071.17% to $2.6 million in 2024, then plunged by 73.96% to $677000.0 in 2025, then surged by 76.51% to $1.2 million in 2026.
- According to Business Quant data, Capital Expenditures over the past three periods registered $1.2 million, $677000.0, and $3.0 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capital Expenditures (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -8,939.03 |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 43.25 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 133.40 Mn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 230.60 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 786,000.00 |
| 10 | Zai Lab | 22.02 Bn | 22.02 Bn | 61.30 Mn | 1.20 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.20 Mn |
| Mar 31, 2026 | 1.20 Mn |
| Dec 31, 2025 | 677,000.00 |
| Dec 31, 2025 | 677,000.00 |
| Sep 30, 2025 | 3.01 Mn |
| Sep 30, 2025 | 3.01 Mn |
| Jun 30, 2025 | 2.89 Mn |
| Jun 30, 2025 | 2.89 Mn |
| Mar 31, 2025 | 1.53 Mn |
| Mar 31, 2025 | 1.53 Mn |
| Dec 31, 2024 | 2.60 Mn |
| Dec 31, 2024 | 2.60 Mn |
| Sep 30, 2024 | 1.34 Mn |
| Sep 30, 2024 | 1.34 Mn |
| Jun 30, 2024 | 741,000.00 |
| Jun 30, 2024 | 741,000.00 |
| Mar 31, 2024 | 974,000.00 |
| Mar 31, 2024 | 974,000.00 |
| Dec 31, 2023 | 222,000.00 |
| Dec 31, 2023 | 222,000.00 |